Chemotherapy treatment for cancer, applied in most anti-cancer treating hospitals, generates a number of physical side effects. These side effects include low blood count, nausea, diarrhea, oral lesions and alopecia, otherwise known as hair loss. Varying degrees of alopecia, induced by chemotherapy drugs are an outcome of the interaction between chemotherapy treatment and cell division. In effect these drugs interfere with cell division, and cause changes to the digestive system, bone marrow and hair follicles, where rapidly dividing cells are produced. Partial or even complete baldness may seem like a minor price to pay for an extended life, or even a total cure from cancer. However the psychological impact on the patient can be devastating and even life threatening. It can influence some patients to completely refuse cytotoxic chemotherapy treatment.
In the not-so-distant past initial attempts at scalp cooling were made by placing crushed ice in plastic bags on the patient's head. This first anti-hair-loss treatment was followed by vinyl-filled crylon gel caps. But these products have limited therapeutic value; crushed ice melts and gel-insulated caps are uncomfortably cold.
Such methods have also been unsuccessful in patients with Hepatic Metastases.
As opposed to previous treatments Amit Technology Science and Medicine Ltd. has invented a high-technology solution to this severe side effect: The SCS II System is a painless hair-loss prevention device for patients undergoing chemotherapy.
Designed as a hat, the SCS II cap is worn on the patient's head providing comfort and ease of use. Ultimately hair loss is prevented and problems previously associated with cold therapy treatment are eliminated.
Two Patients Receiving Treatment